AHZ has been very quiet on immunotherapies of late.
We had some patent updates around HSV2 recently, so I speculate they learnt something last trial that they want to secure ownership of.
Now this news release to market.
Maybe, just a way of reminding the market there is still a sniff of blue sky events possible around AHZ
AHZ has been very quiet on immunotherapies of late. We had some...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.69 |
Change
0.090(0.48%) |
Mkt cap ! $354.6M | |||
| Open | High | Low | Value | Volume |
| $18.62 | $18.70 | $18.45 | $130.9K | 7.041K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $18.60 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.90 | 500 | 1 |
View Market Depth
| Last trade - 16.10pm 24/06/2024 (20 minute delay) ? |
| AVR (ASX) Chart |